LISBON, Portugal (AP) — Researchers in the United States and Britain are sharing a 1 million-euro ($1.16 million) prize from a Portuguese scientific foundation for developing revolutionary gene therapy that has restored the sight of children.
The Lisbon, Portugal-based Champalimaud Foundation’s annual Vision Award was given Tuesday for work on the treatment of children blinded from birth by genetic disease.
The foundation says the research brought a medical revolution, paving the way for new treatment of genetic conditions.
The winners are Michael Redmond of the U.S. National Eye Institute, who conducted pioneering early research in the field, and research teams in Pennsylvania, Florida and London, which built on that work.
Most Read Nation & World Stories
- Did you see that painting hanging behind Trump during ‘60 Minutes’ interview? Here's what we know about it
- Mueller said ready to deliver key findings in his Trump probe
- America's most famous pimp, poised for elected office, dies
- Audio offers gruesome details of Khashoggi killing, Turkish official says
- Collins' husband: Ricin threat mentioned Kavanaugh vote